Market closed
LeMaitre Vascular/$LMAT
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About LeMaitre Vascular
LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.
Ticker
$LMAT
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
622
Website
LMAT Metrics
BasicAdvanced
$2.1B
Market cap
50.59
P/E ratio
$1.82
EPS
0.89
Beta
$0.64
Dividend rate
0.69%
Dividend yield
Price and volume
Market cap
$2.1B
Beta
0.89
52-week high
$107.03
52-week low
$52.88
Average daily volume
181K
Dividend rate
$0.64
Financial strength
Current ratio
7.74
Quick ratio
5.322
Long term debt to equity
4.713
Total debt to equity
5.535
Dividend payout ratio (TTM)
33.63%
Management effectiveness
Return on assets (TTM)
8.72%
Return on equity (TTM)
13.33%
Valuation
Price to earnings (TTM)
50.59
Price to revenue (TTM)
9.684
Price to book
6.26
Price to tangible book (TTM)
9.09
Price to free cash flow (TTM)
61.599
Dividend yield (TTM)
0.69%
Forward dividend yield
0.69%
Growth
Revenue change (TTM)
14.81%
Earnings per share change (TTM)
49.21%
3-year revenue growth (CAGR)
11.79%
3-year earnings per share growth (CAGR)
11.08%
3-year dividend per share growth (CAGR)
13.41%
What the Analysts think about LMAT
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for LeMaitre Vascular stock.
LMAT Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
LMAT Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
LMAT News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for LeMaitre Vascular stock?
LeMaitre Vascular (LMAT) has a market cap of $2.1B as of December 21, 2024.
What is the P/E ratio for LeMaitre Vascular stock?
The price to earnings (P/E) ratio for LeMaitre Vascular (LMAT) stock is 50.59 as of December 21, 2024.
Does LeMaitre Vascular stock pay dividends?
Yes, the LeMaitre Vascular (LMAT) stock pays dividends to shareholders. As of December 21, 2024, the dividend rate is $0.64 and the yield is 0.69%. LeMaitre Vascular has a payout ratio of 33.63% on a trailing twelve-month basis.
When is the next LeMaitre Vascular dividend payment date?
The next LeMaitre Vascular (LMAT) dividend payment date is unconfirmed.
What is the beta indicator for LeMaitre Vascular?
LeMaitre Vascular (LMAT) has a beta rating of 0.89. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.